| Application no. and date | 20804531.0 (espacenet) (Federated) (European Patent Register), 20201111 | | Patent/reg. no. and date | DK/EP 4058060, 20250219 | | Publication date | 20220921 | | Priority no. and date | US 201962933672 P, 20191111, US 202063031848 P, 20200529, US 202063089345 P, 20201008 | | EP pub. no. and date |
EP 4058060 20220921 | | Effective date | | | Applicant/owner | Astrazeneca AB, 151 85 Södertälje, SE | | Applicant ref. no. | BB337394EPDK | | Inventor | BERGLIND, Anna, AstraZeneca AB
151 85 Södertälje, SE,
ABREU, Gabriel, AstraZeneca AB
151 85 Södertälje, SE,
PINEDA, Lilia, AstraZeneca Pharmaceuticals LP
1800 Concord Pike
Wilmington, Delaware 19850, US,
TUMMALA, Raj, AstraZeneca Pharmaceuticals LP
1800 Concord Pike
Wilmington, Delaware 19850, US,
ASKANASE, Anca, Department of Medicine
Division of Rheumatology
Columbia University College of
Physicians & Surgeons
161 Fort Washington Avenue
New York, NY 10032, US,
RICHEZ, Christophe, Rheumatology Department
CHU de Bordeaux-GH Pellegrin
and UMR CNRS 5164
Bordeaux University
146 rue Léo-Saignat
33076 Bordeaux, FR,
MORAND, Eric, Centre for Inflammatory Disease
Level 5, Block E Monash Medical Centre
Monash University
246 Clayton Road
Clayton, Victoria 3168, AU,
BRUCE, Ian, Centre for Epidemiology Versus Arthritis
Second floor Stopford Building
The University of Manchester
Oxford Road
Manchester M13 9PT, GB,
BROHAWN, Philip, AstraZeneca UK Limited
1 Francis Crick Avenue
Cambridge Biomedical Campus
Cambridge Cambridgeshire CB2 0AA, GB,
FURIE, Richard, Division of Rheumatology
Zucker School of Medicine
at Hofstra/Northwell
Great Neck
500 Hofstra Blvd
Hempstead, NY 11549, US,
BAE, Sang-Cheol, Department of Rheumatology
Hanyang University Hospital for
Rheumatic Diseases
222-1 Wangsimni-ro, Seongdong-gu
Seoul 04763, KR,
TANAKA, Yoshiya, The First Department of Internal Medicine
School of Medicine University of Occupational
and Environmental Health 1-1, Iseigaoka
Kitakyushu, 807-8555, JP,
WERTH, Victoria, University of Pennsylvania
Philadelphia, Pennsylvania 19104, US,
VOLLENHOVEN, Ronald Van, Department of Rheumatology
Amsterdam Rheumatology and
Immunology Center
PO Box 7057
1007 MB Amsterdam, NL,
ISENBERG, David, Centre for Rheumatology, University College
London Rayne Building 4th Floor
5 University Street
London WC1E 6JF, GB,
VITAL, Ed, NIHR Leeds Biomedical Research Centre at Leeds
Teaching Hospitals NHS Trust
Chapeltown Road
Leeds LS7 4SA, GB,
KAHLENBERG, Michelle, Division of Rheumatology, University of Michigan
Ann Arbor, Michigan 48109-5422, US,
KALYANI, Rubana, MedImmune, LLC, One MedImmune Way
Gaithersburg, Maryland 20878, US,
KALUNIAN, Kenneth, University of California
San Diego Health
8910 Villa La Jolla Drive
La Jolla, California 92037, US | | Representative | Novagraaf Brevets, Bâtiment O2, 2 rue Sarah Bernhardt CS90017
F-92665 Asnières-sur-Seine cedex, FR | | Opponent | | | IPC Class | A61K 39/395 (2006.01) , A61P 37/00 (2006.01) | | Title | TYPE I-INTERFERON-HÆMNING VED SYSTEMISK LUPUS ERYTHEMATOSUS | | Int. application no. | EP2020081770 | | Int. publication no. | WO2021094378 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
